
Roche Holding AG
RO · SW · Healthcare / Drug Manufacturers - General
Price History
Full chartMarket Stats
About
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. Roche Holding AG has a collaboration agreement with Excalipoint Therapeutics to evaluate EXP011 in DLL3-expressing solid tumors. The company was founded in 1896 and is based in Basel, Switzerland.
Company Details
- SectorHealthcare
- IndustryDrug Manufacturers - General
- CEODr. Thomas Schinecker
- Employees103.25K
- HeadquartersGrenzacherstrasse 124, Basel, Switzerland, 4070, Switzerland
- Websitehttps://www.roche.com
Leadership
- Dr. Severin Schwan Ph.D.Executive Chairman · b. 1967
- Dr. Thomas SchineckerGroup Chief Executive Officer · b. 1975
- Dr. Alan HippeChief Financial Officer · b. 1967
- Ms. Wafaa MamilliChief Digital & Technology Officer · b. 1967
- Dr. Bruno EschliHead of Investor Relations
- Ms. Claudia BockstiegelGeneral Counsel · b. 1964
- Dr. Nina Schwab-HautzingerHead of Group Communications · b. 1975
- Ms. Maria Cristina A. WilburChief People Officer · b. 1967
- Dr. Nicolas DunantHead of Group Media Relations
- Mr. Boris L. ZaitraHead of Corporate Business Development · b. 1972
Financials
Income Statement
Balance Sheet
Cash Flow
Earnings
Key Statistics & Ratios
Dividends
Stock Splits
- May 4, 2001100:1